Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnosis of Von Hippel-Lindau Syndrome Via Pancreatic Cyst Fluid Next-Generation Sequencing. | ACG Case Rep J | 2026 | 41710795 | PubTator, text mining | PubMed |
| Preliminary study of cyto-impedance: Molecular profiling of functional impedance in motility-promoting treatment of normal cells. | Biochem Biophys Rep | 2026 | 41685087 | PubTator, text mining | PubMed |
| A system-level metastable model of cancer evolution: integrating replication stress, cell cycle deregulation and chromosomal instability. | Ann Med | 2026 | 41606986 | PubTator, text mining | PubMed |
| Identifying and capitalizing on unique molecular alterations of mucinous ovarian carcinoma for the development of novel therapeutic strategies. | Gynecol Oncol Rep | 2026 | 41567617 | PubTator, text mining | PubMed |
| Mutational patterns and ancestry-linked profiles in a large hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma cohort. | ESMO Open | 2026 | 41564818 | PubTator, text mining | PubMed |
| Gene, genetics and genetic medicines in gastroenterology: Current status and its future. | World J Gastroenterol | 2026 | 41551533 | PubTator, text mining | PubMed |
| Genetic differences in familial adenomatous polyposis syndrome in a Hungarian population: A prospective single center study. | World J Gastroenterol | 2026 | 41551532 | PubTator, text mining | PubMed |
| From bench to bedside: pancreatic juice as a platform for biomarker discovery in pancreatic disease. | Korean J Intern Med | 2026 | 41531214 | PubTator, text mining | PubMed |
| RSPO4 exerts tumor suppression through antagonizing canonical and non-canonical Wnt signaling. | Int J Biol Sci | 2026 | 41522353 | PubTator, text mining | PubMed |
Comparison between germline and somatic loss-of-function RNF43 mutations reveals different genotype-phenotype associations and provides insights into the genetic mechanisms of colorectal tumourigenesis. | Gut | 2026 | 41443981 | PubTator, text mining | PubMed |
| A high-throughput approach to optimize and understand nanoparticle protein degraders. | Nanoscale Adv | 2026 | 41334459 | PubTator, text mining | PubMed |
| MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance. | Nature | 2026 | 41286180 | PubTator, text mining | PubMed |
| Brd4 BD1 Domain Antagonism of MS436 Preserves Blood-Brain Barrier Integrity via Rnf43/β-Catenin Signaling Pathway. | Adv Sci (Weinh) | 2026 | 41267382 | PubTator, text mining | PubMed |
| Current Therapies and Potential Strategies for Uveal Melanoma. | Drugs Drug Candidates | 2025 | 41737289 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of RNF43 and Its Co-expressors As Prognostic Biomarkers for Gastric Cancer. | Cureus | 2025 | 41487817 | PubTator, text mining | PubMed |
| Early mutational events and clonal dynamics in normal crypts: implications for colorectal tumorigenesis. | Hum Genomics | 2025 | 41392153 | PubTator, text mining | PubMed |
| Cystic tumors of the pancreas: Current perspectives on diagnosis and management. | World J Gastroenterol | 2025 | 41358177 | PubTator, text mining | PubMed |
| WNK kinase regulates plasma membrane levels of the WNT inhibitor RNF43: A WNK-RNF43 circuit regulates WNT signal suppression. | bioRxiv | 2025 | 41279358 | PubTator, text mining | PubMed |
| A set cover algorithm identifies minimal circulating tumour DNA sequencing targets for colorectal cancer detection. | Sci Rep | 2025 | 41266409 | PubTator, text mining | PubMed |
| Management of recalcitrant colorectal adenoma with endoscopic mucosal resection. | JPGN Rep | 2025 | 41245019 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=3